Phase III trials of eribulin mesylate (E7389) in extensively pretreated patients with locally recurrent or metastatic breast cancer (Q42653377)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III trials of eribulin mesylate (E7389) in extensively pretreated patients with locally recurrent or metastatic breast cancer |
scientific article |
Statements
1 reference
Phase III trials of eribulin mesylate (E7389) in extensively pretreated patients with locally recurrent or metastatic breast cancer (English)
1 reference
1 reference
Chris Twelves
1 reference
Jantien Wanders
1 reference
Corina Akerele
1 reference
Peter A Kaufman
1 reference
1 April 2010
1 reference
1 reference
Identifiers
1 reference